InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Paul Andrea. Officer active across 1 company, notably Zentalis Pharmaceuticals, Inc.. In total, 3 disclosures have been recorded. Activity tracked since 1 February 2023. The latest transaction was filed on 3 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条